283 related articles for article (PubMed ID: 27532546)
1. MYO5B mutations cause cholestasis with normal serum gamma-glutamyl transferase activity in children without microvillous inclusion disease.
Gonzales E; Taylor SA; Davit-Spraul A; Thébaut A; Thomassin N; Guettier C; Whitington PF; Jacquemin E
Hepatology; 2017 Jan; 65(1):164-173. PubMed ID: 27532546
[TBL] [Abstract][Full Text] [Related]
2. MYO5B and bile salt export pump contribute to cholestatic liver disorder in microvillous inclusion disease.
Girard M; Lacaille F; Verkarre V; Mategot R; Feldmann G; Grodet A; Sauvat F; Irtan S; Davit-Spraul A; Jacquemin E; Ruemmele F; Rainteau D; Goulet O; Colomb V; Chardot C; Henrion-Caude A; Debray D
Hepatology; 2014 Jul; 60(1):301-10. PubMed ID: 24375397
[TBL] [Abstract][Full Text] [Related]
3. MYO5B Gene Mutations: A Not Negligible Cause of Intrahepatic Cholestasis of Infancy With Normal Gamma-Glutamyl Transferase Phenotype.
Matarazzo L; Bianco AM; Athanasakis E; Serveres M; Francalanci P; Cenacchi G; Maggiore G; D'Adamo AP
J Pediatr Gastroenterol Nutr; 2022 May; 74(5):e115-e121. PubMed ID: 35129155
[TBL] [Abstract][Full Text] [Related]
4. Defects in myosin VB are associated with a spectrum of previously undiagnosed low γ-glutamyltransferase cholestasis.
Qiu YL; Gong JY; Feng JY; Wang RX; Han J; Liu T; Lu Y; Li LT; Zhang MH; Sheps JA; Wang NL; Yan YY; Li JQ; Chen L; Borchers CH; Sipos B; Knisely AS; Ling V; Xing QH; Wang JS
Hepatology; 2017 May; 65(5):1655-1669. PubMed ID: 28027573
[TBL] [Abstract][Full Text] [Related]
5. Mutations in Myosin 5B in Children With Early-onset Cholestasis.
Cockar I; Foskett P; Strautnieks S; Clinch Y; Fustok J; Rahman O; Sutton H; Mtegha M; Fessatou S; Kontaki E; Papaevangelou V; Deheragoda M; Thompson RJ; Grammatikopoulos T
J Pediatr Gastroenterol Nutr; 2020 Aug; 71(2):184-188. PubMed ID: 32304554
[TBL] [Abstract][Full Text] [Related]
6. MYO5B Pathogenic Variants Found to Cause Intestinal Symptoms Without Microvillus Inclusion Disease in a Child Who Previously Underwent Liver Transplantation for PFIC-like Cholestasis.
Jarasvaraparn C; He M; Granadillo JL; Kulkarni S; Stoll J; Liss K
J Pediatr Gastroenterol Nutr; 2021 Jan; 72(1):e22-e24. PubMed ID: 32459745
[TBL] [Abstract][Full Text] [Related]
7. Unequal Effects of Myosin 5B Mutations in Liver and Intestine Determine the Clinical Presentation of Low-Gamma-Glutamyltransferase Cholestasis.
van IJzendoorn SCD; Li Q; Qiu YL; Wang JS; Overeem AW
Hepatology; 2020 Oct; 72(4):1461-1468. PubMed ID: 32583448
[No Abstract] [Full Text] [Related]
8. Myosin Vb uncoupling from RAB8A and RAB11A elicits microvillus inclusion disease.
Knowles BC; Roland JT; Krishnan M; Tyska MJ; Lapierre LA; Dickman PS; Goldenring JR; Shub MD
J Clin Invest; 2014 Jul; 124(7):2947-62. PubMed ID: 24892806
[TBL] [Abstract][Full Text] [Related]
9. Editing Myosin VB Gene to Create Porcine Model of Microvillus Inclusion Disease, With Microvillus-Lined Inclusions and Alterations in Sodium Transporters.
Engevik AC; Coutts AW; Kaji I; Rodriguez P; Ongaratto F; Saqui-Salces M; Medida RL; Meyer AR; Kolobova E; Engevik MA; Williams JA; Shub MD; Carlson DF; Melkamu T; Goldenring JR
Gastroenterology; 2020 Jun; 158(8):2236-2249.e9. PubMed ID: 32112796
[TBL] [Abstract][Full Text] [Related]
10. MYO5B-associated diseases: Novel liver-related variants and genotype-phenotype correlation.
Wang L; Qiu YL; Xu HM; Zhu J; Li SJ; OuYang WX; Yang YF; Lu Y; Xie XB; Xing QH; Wang JS
Liver Int; 2022 Feb; 42(2):402-411. PubMed ID: 34811877
[TBL] [Abstract][Full Text] [Related]
11. An overview and online registry of microvillus inclusion disease patients and their MYO5B mutations.
van der Velde KJ; Dhekne HS; Swertz MA; Sirigu S; Ropars V; Vinke PC; Rengaw T; van den Akker PC; Rings EH; Houdusse A; van Ijzendoorn SC
Hum Mutat; 2013 Dec; 34(12):1597-605. PubMed ID: 24014347
[TBL] [Abstract][Full Text] [Related]
12. A Functional Relationship Between UNC45A and MYO5B Connects Two Rare Diseases With Shared Enteropathy.
Li Q; Zhou Z; Sun Y; Sun C; Klappe K; van IJzendoorn SCD
Cell Mol Gastroenterol Hepatol; 2022; 14(2):295-310. PubMed ID: 35421597
[TBL] [Abstract][Full Text] [Related]
13. [Clinical features and MYO5B mutations of a family affected by microvillus inclusion disease].
Cheng Y; Liang H; Cai NL; Guo L; Huang YG; Song YZ
Zhongguo Dang Dai Er Ke Za Zhi; 2017 Sep; 19(9):968-974. PubMed ID: 28899465
[TBL] [Abstract][Full Text] [Related]
14. Microvillus inclusion disease with novel MYO5B pathogenic variants.
Kwon R; Huang J; Oshima K; Warren M; Voltaggio L; Wang Y; Montgomery EA; Hutchings D
Histopathology; 2021 Jul; 79(1):119-121. PubMed ID: 33544913
[No Abstract] [Full Text] [Related]
15. Microvillous atrophy: atypical presentations.
Perry A; Bensallah H; Martinez-Vinson C; Berrebi D; Arbeille B; Salomon J; Goulet O; Marinier E; Drunat S; Samson-Bouma ME; Gérard B; Hugot JP
J Pediatr Gastroenterol Nutr; 2014 Dec; 59(6):779-85. PubMed ID: 25111220
[TBL] [Abstract][Full Text] [Related]
16. MYO5B mutations in patients with microvillus inclusion disease presenting with transient renal Fanconi syndrome.
Golachowska MR; van Dael CM; Keuning H; Karrenbeld A; Hoekstra D; Gijsbers CF; Benninga MA; Rings EH; van Ijzendoorn SC
J Pediatr Gastroenterol Nutr; 2012 Apr; 54(4):491-8. PubMed ID: 22441677
[TBL] [Abstract][Full Text] [Related]
17. Compound Heterozygous MYO5B Mutation, a Cause of Infantile Cholestasis: A Case Report.
Khanal M; Jha AK; Sharma AK
JNMA J Nepal Med Assoc; 2022 Sep; 60(253):821-824. PubMed ID: 36705120
[TBL] [Abstract][Full Text] [Related]
18. Loss-of-function of MYO5B is the main cause of microvillus inclusion disease: 15 novel mutations and a CaCo-2 RNAi cell model.
Ruemmele FM; Müller T; Schiefermeier N; Ebner HL; Lechner S; Pfaller K; Thöni CE; Goulet O; Lacaille F; Schmitz J; Colomb V; Sauvat F; Revillon Y; Canioni D; Brousse N; de Saint-Basile G; Lefebvre J; Heinz-Erian P; Enninger A; Utermann G; Hess MW; Janecke AR; Huber LA
Hum Mutat; 2010 May; 31(5):544-51. PubMed ID: 20186687
[TBL] [Abstract][Full Text] [Related]
19. A Molecular Mechanism Underlying Genotype-Specific Intrahepatic Cholestasis Resulting From MYO5B Mutations.
Overeem AW; Li Q; Qiu YL; Cartón-García F; Leng C; Klappe K; Dronkers J; Hsiao NH; Wang JS; Arango D; van Ijzendoorn SCD
Hepatology; 2020 Jul; 72(1):213-229. PubMed ID: 31750554
[TBL] [Abstract][Full Text] [Related]
20. [Phenotypic and genetic analysis of a family affected with microvillus inclusion disease].
Mao M; Guo L; Zhang Z; Wang B; Huang S; Song Y; Chen F; Wen W
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2016 Dec; 33(6):792-796. PubMed ID: 27984607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
